Drug Profile
Malaria vaccine - Crucell
Alternative Names: Ad35-CSLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Crucell
- Developer Crucell; National Institute of Allergy and Infectious Diseases; PATH
- Class Antimalarials; Parasitic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Malaria
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for phase-I development in Malaria in Burkina Faso (Injection)
- 04 Nov 2017 No recent reports of development identified for phase-I development in Malaria(In volunteers) in USA (Injection)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Malaria in Netherlands (Injection)